Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,026 public trials 2,026 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL

NCT02564744

Conditions
B-cell Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Carle Foundation Hospital, Cancer Center Urbana, Illinois, United States
  • Abbott Northwestern Hospital, Virginia Piper Cancer Institute Minneapolis, Minnesota, United States
  • Novant Health Oncology Winston-Salem, North Carolina, United States
View all 39 locations
View Trial Details
Completed

A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

NCT01716806

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama - Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Urological Institute Anchorage, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
View all 54 locations
View Trial Details
Completed

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

NCT03424603

Conditions
B Cells--Tumors, B-cell Lymphoma, Blood Protein Disorders, +26 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC--HOPE Division Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors

NCT05093322

Conditions
Ewing Sarcoma, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Childrens Hospital Orange County Orange, California, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details
Completed

Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma

NCT02348216

Conditions
Hemic and Lymphatic Diseases, High Grade B-cell Lymphoma (HGBCL), Immune System Diseases, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego (UCSD) La Jolla, California, United States
  • Stanford University Palo Alto, California, United States
View all 36 locations
View Trial Details

Related conditions